| Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1 E Mamcarz, S Zhou, T Lockey, H Abdelsamed, SJ Cross, G Kang, Z Ma, ... New England Journal of Medicine 380 (16), 1525-1534, 2019 | 263 | 2019 |
| Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia W Leung, CH Pui, E Coustan-Smith, J Yang, D Pei, K Gan, A Srinivasan, ... Blood, The Journal of the American Society of Hematology 120 (2), 468-472, 2012 | 226 | 2012 |
| High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia W Leung, D Campana, J Yang, D Pei, E Coustan-Smith, K Gan, ... Blood, The Journal of the American Society of Hematology 118 (2), 223-230, 2011 | 214 | 2011 |
| Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors W Leung, R Iyengar, B Triplett, V Turner, FG Behm, MS Holladay, ... The Journal of Immunology 174 (10), 6540-6545, 2005 | 191 | 2005 |
| Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease MH Dallas, B Triplett, DR Shook, C Hartford, A Srinivasan, J Laver, ... Biology of Blood and Marrow Transplantation 19 (5), 820-830, 2013 | 159 | 2013 |
| Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis HA Abdelsamed, A Moustaki, Y Fan, P Dogra, HE Ghoneim, CC Zebley, ... Journal of Experimental Medicine 214 (6), 1593-1606, 2017 | 145 | 2017 |
| Final results from a defibrotide treatment‐IND study for patients with hepatic veno‐occlusive disease/sinusoidal obstruction syndrome NA Kernan, S Grupp, AR Smith, S Arai, B Triplett, JH Antin, L Lehmann, ... British journal of haematology 181 (6), 816-827, 2018 | 113 | 2018 |
| Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies BM Triplett, DR Shook, P Eldridge, Y Li, G Kang, M Dallas, C Hartford, ... Bone marrow transplantation 50 (7), 968-977, 2015 | 109 | 2015 |
| A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia R Nguyen, H Wu, S Pounds, H Inaba, RC Ribeiro, D Cullins, B Rooney, ... Journal for ImmunoTherapy of Cancer 7, 1-7, 2019 | 91 | 2019 |
| Earlier defibrotide initiation post‐diagnosis of veno‐occlusive disease/sinusoidal obstruction syndrome improves Day+ 100 survival following haematopoietic stem cell … PG Richardson, AR Smith, BM Triplett, NA Kernan, SA Grupp, JH Antin, ... British journal of haematology 178 (1), 112-118, 2017 | 85 | 2017 |
| Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy MR Hines, C Keenan, G Maron Alfaro, C Cheng, Y Zhou, A Sharma, ... British journal of haematology 194 (4), 701-707, 2021 | 80 | 2021 |
| Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation H Inaba, J Yang, SC Kaste, CM Hartford, MS Motosue, W Chemaitilly, ... Journal of clinical oncology 30 (32), 3991-3997, 2012 | 80 | 2012 |
| A phase II trial of Hu14. 18K322A in combination with induction chemotherapy in children with newly diagnosed high-risk neuroblastoma WL Furman, SM Federico, MB McCarville, BL Shulkin, AM Davidoff, ... Clinical Cancer Research 25 (21), 6320-6328, 2019 | 71 | 2019 |
| Improved outcome in children with newly diagnosed high-risk neuroblastoma treated with chemoimmunotherapy: updated results of a phase II study using hu14. 18K322A WL Furman, B McCarville, BL Shulkin, A Davidoff, M Krasin, CW Hsu, ... Journal of Clinical Oncology 40 (4), 335-344, 2022 | 63 | 2022 |
| Defibrotide for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome: interim results from a treatment IND study PG Richardson, AR Smith, BM Triplett, NA Kernan, SA Grupp, JH Antin, ... Biology of blood and marrow transplantation 23 (6), 997-1004, 2017 | 61 | 2017 |
| CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ... Cell reports 37 (9), 2021 | 60 | 2021 |
| Selective T‐cell depletion targeting CD 45 RA reduces viremia and enhances early T‐cell recovery compared with CD 3‐targeted T‐cell depletion BM Triplett, B Muller, G Kang, Y Li, SJ Cross, J Moen, L Cunningham, ... Transplant Infectious Disease 20 (1), e12823, 2018 | 60 | 2018 |
| Natural killer cell therapy in children with relapsed leukemia JE Rubnitz, H Inaba, G Kang, K Gan, C Hartford, BM Triplett, M Dallas, ... Pediatric blood & cancer 62 (8), 1468-1472, 2015 | 58 | 2015 |
| Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability DR Shook, BM Triplett, PW Eldridge, G Kang, A Srinivasan, W Leung Pediatric blood & cancer 62 (4), 666-673, 2015 | 57 | 2015 |
| Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation H Inaba, CM Hartford, D Pei, MJ Posner, J Yang, RT Hayden, ... British journal of haematology 156 (1), 109-117, 2012 | 55 | 2012 |
